Evidence map›Paper›PMID 41593078›Full record

ArticleNature communications2026

The functional landscape of alternative splicing in hematopoietic lineage commitment.

Xiao Hu, Jinrui Wang, Li Chen, Qin Yang, Manuel Tardaguila, Bin Mao, Shenghui Niu, Zijie Xu, GuiHua Wang, Dan Zhang and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Xiao Hu *Department of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
Jinrui Wang *Department of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
Li Chen *Biosafety Laboratory of West China Hospital, Center for Biological and Translational Research, West China Hospital, Sichuan University, Chengdu, China.
Qin Yang *Department of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
Manuel Tardaguila *Human Technopole, Fondazione Human Technopole, Milan, Italy.
Bin MaoDepartment of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
Shenghui NiuDepartment of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
Zijie XuDepartment of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
GuiHua WangDepartment of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
Dan ZhangDepartment of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.ORCID 0000-0001-5897-245X
Yating ZhangDepartment of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
Zhen ZhouDepartment of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
Jing LuoDepartment of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
Zhifeng HeDepartment of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
Defu LiuDepartment of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.ORCID 0000-0001-6107-4861
Chao TangBiosafety Laboratory of West China Hospital, Center for Biological and Translational Research, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0003-2524-8451
Nicole SoranzoHuman Technopole, Fondazione Human Technopole, Milan, Italy. ns6@sanger.ac.uk.ORCID 0000-0003-1095-3852
Jing-Wen LinBiosafety Laboratory of West China Hospital, Center for Biological and Translational Research, West China Hospital, Sichuan University, Chengdu, China. lin.jingwen@scu.edu.cn.
Da JiaDepartment of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China. jiada@scu.edu.cn.ORCID 0000-0002-2205-1998
Lu ChenDepartment of Laboratory Medicine, West China Second University Hospital. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China. luchen@scu.edu.cn.ORCID 0000-0002-1083-9729

Funding

National Key Research and Development Program of ChinaNational Natural Science Foundation of ChinaNational Science Fund for Distinguished Young ScholarsNoncommunicable Chronic Diseases-National Science and Technology
6 · The paper itself

Abstract

Alternative splicing (AS) is a ubiquitous post-transcriptional regulatory mechanism, that has greatly expanded the transcriptomic and proteomic diversity in vertebrates. While gene regulation of hematopoiesis has been extensively researched in vertebrates, the functions of species- and cell lineage-specific splice variants in vertebrates are largely unknown. Here, we curate transcriptomic data on fetal hematopoietic organ development in six vertebrates and hematopoietic cell differentiation in humans and mice. To identify functional exon-skipping events among thousands of cassette exons in protein-coding genes for a specific differentiation lineage and species, we develop a machine-learning model interrogating 19 features including dynamic expression, protein structure, and evolutionary conservation, and integrate them into a single prediction score, named Functional AS Score (FAScore). Using FAScore, we identify four previously-uncharacterized functional AS events in which deletion of the AS exon leads to defects in erythropoiesis and myelopoiesis. Furthermore, we demonstrate that deletion of exon 15 of TBC1D23 reduces erythropoiesis in mice and zebrafish through elevated binding capacity to RANBP2/RANGAP1 leading to increased SUMOylation level of HDAC1. Collectively, our study presents a valuable tool to identify functional exon skipping (ES) events during hematopoietic lineage commitment, and establishes a research paradigm that can be broadly applied to other biological processes.

Indexed as

Alternative SplicingCell LineageHematopoiesisHematopoietic Stem CellsAnimalsCell DifferentiationErythropoiesisExonsHumansMiceMyelopoiesisZebrafish

Identifiers

PMID41593078
PMCPMC12946277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.